ALLMedicine™ Takayasu Arteritis Center
Research & Reviews 591 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077813
Arthritis Research & Therapy; Shi X, Du J et. al.
May 8th, 2022 - Aortic valve involvement is not uncommon in patients with Takayasu arteritis (TAK) and leading to poor prognosis. The aim of our study was to explore the risk factors of aortic valve involvement and to evaluate the prognosis in TAK patients with a...
https://doi.org/10.1016/j.semarthrit.2022.152018
Seminars in Arthritis and Rheumatism; Wang J, Dai X et. al.
May 7th, 2022 - To investigate the efficacy and safety of leflunomide (LEF) versus tofacitinib (TOF) in Takayasu arteritis (TAK) patients. Sixty-seven active patients were recruited from an ongoing observational TAK cohort, including 35 patients treated with gluc...
https://clinicaltrials.gov/ct2/show/NCT04882072
Apr 28th, 2022 - The purpose of this study is to evaluate the efficacy of ustekinumab compared to placebo, in combination with oral glucocorticoid (GC) taper regimen, in participants with relapsing Takayasu Arteritis (TAK).
https://doi.org/10.1007/s10067-022-06168-1 10.3899/jrheum.161514 10.1016/j.kint.2017.06.027 10.5603/NMR.2016.0006 10.1097/MD.0000000000000622 10.1111/jon200010284 10.1007/BF00688476 10.1212/01.WNL.0000058758.47170.AE 10.2169/internalmedicine.50.4332 10.1002/art.1780330811 10.7326/0003-4819-120-11-199406010-00004 10.1016/j.semarthrit.2020.04.003 10.1093/rheumatology/keh664 10.3174/ajnr.A5095 10.1001/archneur.1965.00460250096012 10.1093/rheumatology/keab308 10.1136/ard.2005.047498 10.1016/j.semarthrit.2018.09.001 10.1161/STROKEAHA.112.658500 10.1016/j.jstrokecerebrovasdis.2017.06.056 10.3390/jcdd8020012 10.3899/jrheum.090387 10.1136/annrheumdis-2019-215672 10.1161/CIRCRESAHA.117.311170 10.1007/s00059-008-3152-y
Clinical Rheumatology; Guo Y, Du J et. al.
Apr 20th, 2022 - It has been known that aorta, subclavian, and extracranial arteries are commonly involved in Takayasu arteritis (TA). However, the involvement of intracranial artery in TA has not been well explored. The purpose of this study was to describe the c...
https://doi.org/10.1016/j.amjms.2022.04.004
The American Journal of the Medical Sciences; Meng X, Xue J et. al.
Apr 16th, 2022 - Mid-aortic syndrome (MAS), characterized by segmental stricture of the distal thoracic and abdominal aorta, is a heterogeneous clinical syndrome with multiple etiologies. We retrospectively analyzed 143 consecutive patients (99 females and 44 male...
Guidelines 4 results
https://doi.org/10.1002/acr.24632
Arthritis Care & Research; Maz M, Chung SA et. al.
Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Clinical questions regarding diagnostic testing, treatment, and ma...
https://doi.org/10.1002/art.41774
Arthritis & Rheumatology (Hoboken, N.J.); Maz M, Chung SA et. al.
Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Clinical questions regarding diagnostic testing, treatment, and ma...
https://doi.org/10.1136/annrheumdis-2019-215672
Annals of the Rheumatic Diseases; Hellmich B, Agueda A et. al.
Jul 5th, 2019 - Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which have th...
https://doi.org/10.1016/j.carpath.2015.05.001
Cardiovascular Pathology : the Official Journal of the So... Stone JR, Bruneval P et. al.
Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...
Clinicaltrials.gov 6 results
https://clinicaltrials.gov/ct2/show/NCT04882072
Apr 28th, 2022 - The purpose of this study is to evaluate the efficacy of ustekinumab compared to placebo, in combination with oral glucocorticoid (GC) taper regimen, in participants with relapsing Takayasu Arteritis (TAK).
https://clinicaltrials.gov/ct2/show/NCT04161898
Nov 8th, 2021 - The main objective of this study is to evaluate the efficacy of upadacitinib in combination with a corticosteroid taper regimen compared to placebo in combination with a corticosteroid taper regimen.
https://clinicaltrials.gov/ct2/show/NCT03893136
Aug 10th, 2021 - Overview of Takayasu's arteritis. Takayasu arteritis (TA) is a chronic inflammatory blood vessel that seriously endangers human health, which affects a large variety of blood vessels, characterized by vascular stenosis and occlusion. The clinical ...
https://clinicaltrials.gov/ct2/show/NCT04071691
Jun 23rd, 2021 - Up-regulation of SST2 in activated macrophages represents a novel imaging target for measuring vascular inflammation, which has been previously examined in atherosclerosis using 68Ga-DOTATATE. To test the hypothesis that SST2 PET imaging can accur...
https://clinicaltrials.gov/ct2/show/NCT01611636
Jun 23rd, 2020 - The incidence and prevalence of the allergic, autoimmune and rheumatic diseases are different all over the world. The relative impact of gene and environment on diseases can be revealed by studies from different populations. National Health Insura...
News 26 results
https://www.medscape.com/viewarticle/954873
Jul 15th, 2021 - Three new guidelines from the American College of Rheumatology, in partnership with the Vasculitis Foundation, offer evidence-based recommendations for managing and treating six different forms of systemic vasculitis. Dr Sharon Chung "It's not unu...
https://www.mdedge.com/rheumatology/article/242933/lupus-connective-tissue-diseases/three-new-acr-guidelines-recommend
Steve Cimino
Jul 14th, 2021 - Three new guidelines from the American College of Rheumatology, in partnership with the Vasculitis Foundation, offer evidence-based recommendations for managing and treating six different forms of systemic vasculitis. Dr.
https://www.medscape.com/viewarticle/949813
Apr 23rd, 2021 - An oral Janus kinase 1 (JAK1) inhibitor, upadacitinib (Rinvoq), relieves the symptoms of atopic dermatitis (AD) better than dupilumab (Dupixent), researchers say. "The differences between the two drugs were more pronounced when we looked at higher...
https://www.mdedge.com/infectiousdisease/article/207159/autoimmune-diseases/vasculitis-skin-tells-story?channel=39313
Kari Oakes
Aug 27th, 2019 - MILAN – Skin manifestations of the vasculitides can point the way to an accurate diagnosis and provide clues about disease severity, Robert Micheletti, MD, said at the World Congress of Dermatology. Dr.
https://www.mdedge.com/dermatology/article/207159/autoimmune-diseases/vasculitis-skin-tells-story
Kari Oakes
Aug 27th, 2019 - MILAN – Skin manifestations of the vasculitides can point the way to an accurate diagnosis and provide clues about disease severity, Robert Micheletti, MD, said at the World Congress of Dermatology. Dr.